SONOMA PHARMACEUTICALS INC (SNOA) Stock Income Statement
USA - NASDAQ:SNOA - US83558L3033 - Common Stock
4.06 USD
-0.02 (-0.49%)
| TTM (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.91M | 14.29M | 12.73M | 13.27M | 12.63M | |||
| Cost Of Goods | 9.29M | 8.82M | 7.99M | 8.56M | 8.42M | |||
| Gross Profit | 5.62M | 5.46M | 4.75M | 4.71M | 4.21M | |||
| Operating Expenses | 9.26M | 9.18M | 9.45M | 9.04M | 9.88M | |||
| Research and Development | 1.94M | 1.81M | 1.87M | 210.00K | 130.00K | |||
| Selling, General, and Administrative Expenses | 7.32M | 7.36M | 7.58M | 8.84M | 9.76M | |||
| Operating Income | -3.63M | -3.71M | -4.70M | -4.33M | -5.67M | |||
| Interest Income/Expense | N/A | 243.00K | -825.00K | 20.00K | -10.00K | |||
| Other Income/Expense | 480.00K | 560.00K | 495.00K | -630.00K | -390.00K | |||
| Non Recurring Items | N/A | N/A | N/A | -240.00K | 510.00K | |||
| Income Before Taxes | -3.15M | -2.91M | -5.03M | -5.18M | -5.42M | |||
| Income Tax | 403.00K | 550.00K | -196.00K | -30.00K | -330.00K | |||
| Net Income | -3.56M | -3.46M | -4.83M | -5.15M | -5.09M | |||
| EBITDA | -3.50M | -3.57M | -4.53M | -4.20M | -5.48M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.46 | -2.79 | -10.64 | -1.52 | -1.92 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 37.71% | 38.25% | 37.26% | 35.49% | 33.33% | |||
| Profit Margin | -23.84% | -24.20% | -37.97% | -38.81% | -40.30% | |||
| Operating Profit Margin | -24.36% | -25.97% | -36.91% | -32.63% | -44.89% | |||
All data in USD